Ads
related to: merck+%26+co- Sign In
Sigma® Life Science
View contract pricing, get quotes
- Chemical Synthesis
Organic Building Blocks, Catalysts,
Heterocycles, Ligands, and more.
- Register an Account
Get product updates, special offers
Save favorites & shopping lists
- Solvent Center
Our Solvents include HPLC, ACS,
Anhydrous, Reagent Grade and more
- Stockroom Reagents
Solvents, Acids/Bases, Absorbents,
Filter Aids, Drying Agents and more
- Classic Lab Chemicals
High-quality laboratory reagents.
Solvents, salts, acids, bases
- Sign In
Search results
The Zacks Analyst Blog Highlights Broadcom, Merck, Airbnb, ONEOK and PG&E
Zacks via Yahoo Finance· 5 hours agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and...
Why Merck & Co Inc (NYSE: MRK) Is A Stock Not To Be Discarded In 2024 – Marketing Sentinel
Marketing Sentinel· 3 days agoIn today’s recent session, 2.33 million shares of the Merck & Co Inc (NYSE:MRK) have been traded, and its beta is 0.42. Most recently the company’s share ...
Earnings call: Merck sees organic growth despite market challenges By Investing.com
Investing.com· 22 hours agoMerck & Co., Inc. (MRK) reported its first-quarter results for 2024, revealing a slight decline in...
Merck Ends Co-Formulation Arm of Keytruda High-Risk Melanoma Study
Morningstar· 3 days agoMerck & Co. has ended part of a late-stage study of a co-formulation of its blockbuster cancer drug Keytruda in certain skin-cancer patients because the ...
Merck halts phase 3 TIGIT trial after immune-mediated adverse events prompt discontinuations
FierceBiotech· 3 days agoMerck & Co. has bailed early on a phase 3 test of the anti-TIGIT antibody vibostolimab after a high...
Merck Halts Skin Cancer Drug Trial On High Discontinuation Rate - A Setback in High-Risk Melanoma...
Benzinga via AOL· 3 days agoMonday, Merck & Co Inc (NYSE:MRK) announced the discontinuation of the vibostolimab and...
Merck cancels trial of melanoma treatment due to immune-mediated adverse events
Clinical Trials Arena via Yahoo Finance· 2 days agoUS pharmaceutical company Merck & Co Inc (MSD) has discontinued a Phase III trial investigating a...
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Benzinga via Yahoo Finance· 31 minutes agoOn Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical...
Blackstone unearths Uniquity Bio with $300M to explore Merck drug's I&I potential
FierceBiotech· 1 day agoWhat a time to be launching a new biotech focused on inflammation and immunology. Uniquity Bio is...
Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
Zacks via Yahoo Finance· 2 days agoWith Merck’s growth largely depending on Keytruda, the recent pipeline setbacks do not bode well for...
